15-deoxy-Δ 12,14-prostaglandin J2 exerts pro- and anti-inflammatory effects in mesangial cells in a concentration-dependent manner

Inflammation and Allergy - Drug Targets

Volumn 11, Issue 1, 2012, Pages 58-65

  Martínez, Alma E ^a   Sánchez Gómez, Francisco J ^a   Beatriz, Díez Dacal ^a   Oeste, Clara L ^a   Pérez Sala, Dolores ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Antioxidant response; Cyclopentenone prostaglandins; Inflammation; Inflammatory resolution; Nitric oxide; Nrf2

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CYCLOOXYGENASE 2; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TRANSCRIPTION FACTOR NRF2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; ELECTROPHILICITY; GENE EXPRESSION; HUMAN; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84855846529     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152812798889349     Document Type: Article

References (51)

1. Díez-Dacal, B.; Pérez-Sala, D. Anti-inflammatory prostanoids: focus on the interactions between electrophile signalling and resolution of inflammation. ScientificWorldJournal, 2010, 10, 655-675.
2. Gilroy, D. W.; Colville-Nash, P. R.; Willis, D.; Chivers, J.; Paul-Clark, M. J.; Willoughby, D. A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med., 1999, 5(6), 698-701.
3. Rajakariar, R.; Hilliard, M.; Lawrence, T.; Trivedi, S.; Colville-Nash, P.; Bellingan, G.; Fitzgerald, D.; Yaqoob, M. M.; Gilroy, D. W. Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12, 14 PGJ2. Proc. Natl. Acad Sci. USA, 2007, 104(52), 20979-20984.
4. Paumi, C. M.; Smitherman, P. K.; Townsend, A. J.; Morrow, C. S. Glutathione S-Transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor aa (PPAR() ligand, 15-deoxy-)12,14prostaglandin J2 (15-d-PGJ2). Biochemistry, 2004, 43, 2345-2352.
5. Pérez-Sala, D. Electrophilic eicosanoids: signaling and targets. Chem. Biol. Interact., 2011, 192, 96-100.
6. Oh, J. Y.; Giles, N.; Landar, A.; Darley-Usmar, V. Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. Biochem. J., 2008, 411, (2), 297-306.
7. Shin, S. W.; Seo, C. Y.; Han, H.; Han, J. Y.; Jeong, J. S.; Kwak, J. Y.; Park, J. I. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo, antitumor activity. Clin. Cancer Res., 2009, 15(17), 5414-5425.
8. Prakash, J.; Bansal, R.; Post, E.; de Jager-Krikken, A.; Lub-de Hooge, M. N.; Poelstra, K. Albumin-binding and tumor vasculature determine the antitumor effect of 15-deoxy-Delta-(12,14)-prostaglandin-J(2) in vivo. Neoplasia, 2009, 11, (12), 1348-1358.
9. Bregman, M. D.; Funk, C.; Fukushima, M. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues. Cancer Res., 1986, 46(6), 2740-2744.
10. Sasaki, H.; Niimi, S.; Akiyama, M.; Tanaka, T.; Hazato, A.; Kurozumi, S.; Fukushima, S.; Fukushima, M. Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo. Cancer Res., 1999, 59, 3919-3922.
11. Ricote, M.; Li, A. C.; Willson, T. M.; Kelly, C. J.; Glass, C. K. The peroxisome proliferator-activated receptor-pppis a negative regulator of macrophage activation. Nature, 1998, 391, 79-82.
12. Rossi, A.; Kapahi, P.; Natoli, G.; Takahashi, T.; Chen, Y.; Karin, M.; Santoro, M. G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IttB kinase. Nature, 2000, 403, 103-108.
13. Cernuda-Morollón, E.; Pineda-Molina, E.; Cañada, F. J.; Pérez-Sala, D. 15-Deoxy-SS12,14-prostaglandin J2 inhibition of NF-iiB DNA binding through covalent modification of the p50 subunit. J. Biol. Chem., 2001, 276, 35530-35536.
14. Pérez-Sala, D.; Cernuda-Morollón, E.; Cañada, F. J. Molecular basis for the inhibition of AP-1 DNA binding by 15-deoxy-bb12,14-prostaglandin J2. J. Biol. Chem., 2003, 278, 51251-51260.
15. Cuzzocrea, S.; Wayman, N. S.; Mazzon, E.; Dugo, L.; Di Paola, R.; Serraino, I.; Britti, D.; Chatterjee, P. K.; Caputi, A. P.; Thiemermann, C. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. Mol. Pharmacol., 2002, 61, (5), 997-1007.
16. Cuzzocrea, S.; Ianaro, A.; Wayman, N. S.; Mazzon, E.; Pisano, B.; Dugo, L.; Serraino, I.; Di Paola, R.; Chatterjee, P. K.; Di Rosa, M.; Caputi, A. P.; Thiemermann, C. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)-PGJ2 attenuates the development of colon injury caused by dinitrobenzene sulphonic acid in the rat. Br. J. Pharmacol., 2003, 138, 678-688.
17. Oliva, J. L.; Pérez-Sala, D.; Castrillo, A.; Martínez, N.; Cañada, F. J.; Boscá, L.; Rojas, J. M. The cyclopentenone 15-deoxy-JJ12,14-prostaglandin J2 binds to and activates H-Ras. Proc. Natl. Acad Sci. U S A., 2003, 100, 4772-4777.
18. Millán, O.; Rico, D.; Peinado, H.; Zarich, N.; Stamatakis, K.; Pérez-Sala, D.; Rojas, J. M.; Cano, A.; Boscá, L. Potentiation of tumor formation by topic administration of 15-deoxy-tt12,14-prostaglandin J2 in a model of skin carcinogenesis. Carcinogenesis, 2006, 27, 328-336.
19. Monneret, G.; Li, H.; Vasilescu, J.; Rokach, J.; Powell, W. S. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. J. Immunol., 2002, 168, (7), 3563-3569.
20. Kobayashi, Y.; Ueki, S.; Mahemuti, G.; Chiba, T.; Oyamada, H.; Saito, N.; Kanda, A.; Kayaba, H.; Chihara, J. Physiological levels of 15-deoxy-Delta12,14-prostaglandin J2 prime eotaxin-induced chemotaxis on human eosinophils through peroxisome proliferatoractivated receptor-gamma ligation. J. Immunol., 2005, 175(9), 5744-5750.
21. Jozkowicz, A.; Was, H.; Taha, H.; Kotlinowski, J.; Mleczko, K.; Cisowski, J.; Weigel, G.; Dulak, J. 15d-PGJ2 upregulates synthesis of IL-8 in endothelial cells through induction of oxidative stress. Antioxid. Redox. Signal, 2008, 10(12), 2035-2046.
22. Sánchez-Gómez, F. J.; Cernuda-Morollón, E.; Stamatakis, K.; Pérez-Sala, D. Protein thiol modification by 15-deoxy-PP12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes. Mol. Pharmacol., 2004, 66, 1349-1358.
23. Saura, M.; Martínez-Dalmau, R.; Minty, A.; Pérez-Sala, D.; Lamas, S. Interleukin-13 inhibits inducible nitric oxide synthase expression in human mesangial cells. Biochem. J., 1996, 313, 641-646.
24. Pérez-Sala, D.; Cernuda-Morollón, E.; Díaz-Cazorla, M.; Rodríguez-Pascual, F.; Lamas, S. Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am. J. Physiol. Renal Physiol., 2001, 280, F466-F473.
25. Cernuda-Morollón, E. Effect of peroxisome proliferators on the cellular response to proinflammatory stimuli: regulation inducible nitric oxide synthase and transcription factor NF-kB. PhD Thesis, Universidad Complutense de Madrid. May 2003.
26. Cernuda-Morollón, E.; Rodríguez-Pascual, F.; Klatt, P.; Lamas, S.; Pérez-Sala, D. PPAR agonists amplify iNOS expression while inhibiting NF-iiB: implications for mesangial cell activation by cytokines. J. Am. Soc. Nephrol., 2002, 13, 2223-2231.
27. Díaz-Cazorla, M.; Pérez-Sala, D.; Lamas, S. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells. J. Am. Soc. Nephrol., 1999, 10, 943-952.
28. Baird, L.; Dinkova-Kostova, A. T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol., 2011, 85(4), 241-272.
29. Itoh, K.; Mochizuki, M.; Ishii, Y.; Ishii, T.; Shibata, T.; Kawamoto, Y.; Kelly, V.; Sekizawa, K.; Uchida, K.; Yamamoto, M. Transcription Factor Nrf2 Regulates Inflammation by Mediating the Effect of 15-Deoxy-Delta(12,14)-Prostaglandin J(2). Mol. Cell. Biol., 2004, 24, 36-45.
30. Paine, A.; Eiz-Vesper, B.; Blasczyk, R.; Immenschuh, S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem. Pharmacol., 2010, 80, (12), 1895-903.
31. Zorrilla, S.; Garzón, B.; Pérez-Sala, D. Selective binding of the fluorescent dye 8-anilinonaphthalene-1-sulfonic acid to PPARff allows ligand identification and characterization. Anal. Biochem., 2010, 399, 84-92.
32. Gandhi, U. H.; Kaushal, N.; Ravindra, K. C.; Hegde, S.; Nelson, S. M.; Narayan, V.; Vunta, H.; Paulson, R. F.; Prabhu, K. S. Selenoprotein-dependent up-regulation of hematopoietic prostaglandin D2 synthase in macrophages is mediated through the activation of peroxisome proliferator-activated receptor (PPAR) gamma. J. Biol. Chem., 2011, 286, (31), 27471-27482.
33. Ishii, T.; Uchida, K. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxydelta(12,14)-prostaglandin J2. Chem. Res. Toxicol., 2004, 17, 1313-1322.
34. Napimoga, M. H.; Vieira, S. M.; Dal-Secco, D.; Freitas, A.; Souto, F. O.; Mestriner, F. L.; Alves-Filho, J. C.; Grespan, R.; Kawai, T.; Ferreira, S. H.; Cunha, F. Q. Peroxisome proliferator-activated receptor-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J2, reduces neutrophil migration via, a nitric oxide pathway. J. Immunol., 2008, 180, (1), 609-617.
35. Peng, H.-B.; Libby, P.; Liao, J. K. Induction and stabilization of IIIBBBBby nitric oxide mediates inhibition of NF-bbB. J. Biol. Chem., 1995, 270, 14214-14219.
36. Rovin, B. H.; Wilmer, W. A.; Lu, L.; Doseff, A. I.; Dixon, C.; Kotur, M.; Hilbelink, T. 15-Deoxy-Delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death. Kidney Int., 2002, 61(4), 1293-1302.
37. Katura, T.; Moriya, T.; Nakahata, N. 15-Deoxy-delta 12,14-prostaglandin J2 biphasically regulates the proliferation of mouse hippocampal neural progenitor cells by modulating the redox state. Mol. Pharmacol., 2010, 77, (4), 601-611.
38. Levonen, A. L.; Dickinson, D. A.; Moellering, D. R.; Mulcahy, R. T.; Forman, H. J.; Darley-Usmar, V. M. Biphasic effects of 15-deoxy-delta(12,14)-prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. Arterioscler. Thromb. Vasc. Biol., 2001, 21, (11), 1846-1851.
39. Cooper, C. E.; Patel, R. P.; Brookes, P. S.; Darley-Usmar, V. M. Nanotransducers in cellular redox signaling: modification of thiols by reactive oxygen and nitrogen species. Trends. Biochem. Sci., 2002, 27(10), 489-492.
40. Hill, B. G.; Dranka, B. P.; Bailey, S. M.; Lancaster, J. R. Jr.; Darley-Usmar, V. M. What part of NO don't you understand? Some answers to the cardinal questions in nitric oxide biology. J. Biol. Chem., 2010, 285(26), 19699-19704.
41. Shiraki, T.; Kamiya, N.; Shiki, S.; Kodama, T. S.; Kakizuka, A.; Jingami, H. a, ß-Unsaturated Ketone is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome proliferator-activated receptor. J. Biol. Chem., 2005, 280, 14145-14153.
42. Paumi, C. M.; Wright, M.; Townsend, A. J.; Morrow, C. S. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. Biochemistry, 2003, 42, 5429-5437.
43. Brunoldi, E. M.; Zanoni, G.; Vidari, G.; Sasi, S.; Freeman, M. L.; Milne, G. L.; Morrow, J. D. Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via, conjugation with glutathione. Chem. Res. Toxicol., 2007, 20, (10), 1528-1535.
44. Renedo, M.; Gayarre, J.; García-Domínguez, C. A.; Pérez-Rodríguez, A.; Prieto, A.; Cañada, F. J.; Rojas, J. M.; Pérez-Sala, D. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. Biochemistry, 2007, 46, 6607-6616.
45. Li, Z.; Jansen, M.; Ogburn, K.; Salvatierra, L.; Hunter, L.; Mathew, S.; Figueiredo-Pereira, M. E. Neurotoxic prostaglandin J2 enhances cyclooxygenase-2 expression in neuronal cells through the p38MAPK pathway: a death wish? J. Neurosci. Res., 2004, 78(6), 824-836.
46. Qin, S.; McLaughlin, A. P.; De Vries, G. W. Protection of RPE cells from oxidative injury by 15-deoxy-delta12,14-prostaglandin J2 by augmenting GSH and activating MAPK. Invest. Ophthalmol. Vis. Sci., 2006, 47, (11), 5098-5105.
47. Sánchez-Gómez, F. J.; Díez-Dacal, B.; Pajares, M. A.; Llorca, O.; Pérez-Sala, D. Cyclopentenone prostaglandins with dienone structure promote cross-linking of the chemoresistance-inducing enzyme Glutathione Transferase P1-1. Mol. Pharmacol., 2010, 78, 723-733.
48. Covey, T. M.; Edes, K.; Coombs, G. S.; Virshup, D. M.; Fitzpatrick, F. A. Alkylation of the tumor suppressor PTEN activates Akt and beta-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer. PLoS One, 2010, 5(10), e13545.
49. Cho, H. Y.; Gladwell, W.; Wang, X.; Chorley, B.; Bell, D.; Reddy, S. P.; Kleeberger, S. R. Nrf2-Regulated PPAR{gamma} Expression is Critical to Protection Against Acute Lung Injury in Mice. Am. J. Respir. Crit. Care Med., 2010, 182, 170-182.
50. Doyle, K.; Fitzpatrick, F. A. Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J. Biol. Chem., 2010, 285, (23), 17417-17424.
51. Cho, H. Y.; Reddy, S. P.; Debiase, A.; Yamamoto, M.; Kleeberger, S. R. Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic. Biol. Med., 2005, 38(3), 325-343.